Taken as a whole, IL-6 and KL-6 are two prognostic biomarkers whose concentrations kinetics, taken independently, seem to evolve in an opposite way over the course of COVID-19 and among the two prevailing phenotypes. Here, MUC1 is linked to COVID-19.